Alignment Healthcare, Inc.
$2.53B- Market cap
- $2.81B
- Debt
- +$323.18M
- Cash
- −$604.23M
Capital structure 90% equity / 10% debt · EV / Revenue 0.64x · EV / EBITDA 53.89x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2026 ·
Decision snapshot: ALHC stock price at discount vs AEHR $13.54 current versus $1.07K implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at AEHR's multiple
Implied fair value · at ALHC's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple discount
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: ALHC FY 2025 (ended Dec 31, 2025) · AEHR FY 2026 (ended May 29, 2026). Fiscal years are not aligned.
Trendline
Seven fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 90% equity / 10% debt · EV / Revenue 0.64x · EV / EBITDA 53.89x
Capital structure 99% equity / 1% debt · EV / Revenue 54.49x
AEHR carries the larger enterprise value at $2.72B against $2.53B; ALHC trades on the lower EV / Revenue multiple (0.64x vs 54.49x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
ALIGNMENT HEALTHCARE, INC. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
AEHR TEST SYSTEMS · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
1.80x
0.12x
Net debt / EBITDA
Leverage against operating earnings
-5.99x
10.74x
Cash and equivalents
Liquid reserves on the balance sheet
$604.23M
$116.36M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Cigna Group
ALHC vs CI
MOLINA HEALTHCARE, INC.
ALHC vs MOH
Elevance Health, Inc.
ALHC vs ELV
CENTENE CORP
ALHC vs CNC
UNITEDHEALTH GROUP INC
ALHC vs UNH
CLOVER HEALTH INVESTMENTS, CORP. /DE
ALHC vs CLOV
TERADYNE, INC
ALHC vs TER
Merck & Co., Inc.
ALHC vs MRK
LAM RESEARCH CORP
ALHC vs LRCX
APPLIED MATERIALS INC /DE
ALHC vs AMAT
SKYWORKS SOLUTIONS, INC.
ALHC vs SWKS
LATTICE SEMICONDUCTOR CORP
ALHC vs LSCC
$323.18M
$27.15M
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.